Insider Transactions Reported by 12 Insiders of SUPERNUS PHARMACEUTICALS, INC.

Symbol
SUPN on Nasdaq
Location
Rockville, MD

Insiders trading volume in the past year

SUPERNUS PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jack A. Khattar President, CEO, Director $110,148,127 -$18,546,714 -14% 09 Oct 2025
Tami Tillotson Martin Sr. V.P., Regulatory Affairs $2,631,048 23 Feb 2024
JOHN M. SIEBERT Director $2,555,624 23 Feb 2024
Frederick M. Hudson Director $2,134,591 -$315,133 -13% 14 Aug 2025
CHARLES W. NEWHALL III Director $1,730,637 -$1,539,270 -47% 21 Nov 2025
Carrolee Barlow Director $1,073,687 22 Feb 2025
Frank Mottola SVP, Chief Tech. Ops. Officer $930,958 -$1,860,640 -67% 19 Dec 2025
GEORGES GEMAYEL Director $919,413 22 Feb 2025
Padmanabh P. Bhatt Sr. VP of IP, CSO $742,610 -$537,466 -42% 18 Dec 2025
Jonathan Rubin SVP, Chief Medical Officer $606,878 -$36,292 -5.6% 25 Sep 2025
TIMOTHY C. DEC Senior Vice-President & CFO $253,934 -$524,092 -67% 22 Aug 2025
Bethany Sensenig Director $177,658 -$226,840 -56% 14 Aug 2025

Recent Insider Transactions by Companies or Individuals for SUPERNUS PHARMACEUTICALS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.